Physiomics plc wins Innovate UK grant
Oxfordshire-based Physiomics plc, a mathematical modelling company operating out of Milton Park, has been awarded a grant by Innovate UK and The Office for Life Sciences as part of the UK Government's Advancing Precision Medicine programme.
The project, named PREDICT-ONC, will cost around £560,000. Physiomics share of this cost, which is £196,251, will be covered mostly by the grant. Other participating parties in the project are Beyond Blood Diagnostics Limited and and Blackpool Teaching Hospitals NHS Foundation Trust.
PREDICT-ONC is designed to generate data to further develop Physiomics' personalised dosing tool which has been funded by previous grants, including Innovate UK once before in 2018.
Visit Hampshire Biz News for bright, upbeat and positive business news from the county
The project will will generate data through an observational clinical trial where patients will be monitored rigorously during their planned course of chemotherapy to gather data on their neutrophil counts, G-CSF treatment and drug-related side-effects.
Physiomics CEO, Dr Jim Millen, said:"We are delighted to have won our fourth Innovate UK award, which we believe is a testimony to the innovative culture of our company.
''This grant gives us a unique opportunity to capitalise on previous grant-funded work in the personalised oncology space, as well as foster our collaboration with Beyond Blood Diagnostics Ltd, and we are looking forward to working with new partner, Blackpool Teaching Hospitals NHS Foundation Trust."
Read more - Ontic inks new product license agreement with long term US partner